472 related articles for article (PubMed ID: 25591843)
1. miR-214: a potential biomarker and therapeutic for different cancers.
Sharma T; Hamilton R; Mandal CC
Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843
[TBL] [Abstract][Full Text] [Related]
2. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
3. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
5. MiRNAs as biomarkers and therapeutic targets in cancer.
Heneghan HM; Miller N; Kerin MJ
Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
[TBL] [Abstract][Full Text] [Related]
6. Roles of microRNAs in cancers and development.
Takasaki S
Methods Mol Biol; 2015; 1218():375-413. PubMed ID: 25319665
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression signatures in solid malignancies.
Galasso M; Sandhu SK; Volinia S
Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS; Dutta A
Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
[TBL] [Abstract][Full Text] [Related]
9. Insights into the potential use of microRNAs as biomarker in cancer.
Anindo MI; Yaqinuddin A
Int J Surg; 2012; 10(9):443-9. PubMed ID: 22906693
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
[TBL] [Abstract][Full Text] [Related]
11. The diverse role of miR-31 in regulating cancer associated phenotypes.
Laurila EM; Kallioniemi A
Genes Chromosomes Cancer; 2013 Dec; 52(12):1103-13. PubMed ID: 23999990
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in human cancer: from research to therapy.
Negrini M; Ferracin M; Sabbioni S; Croce CM
J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
[TBL] [Abstract][Full Text] [Related]
14. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
15. miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects.
Rizos E; Siafakas N; Koumarianou A; Katsantoni E; Filippopoulou A; Ntounas P; Touloumis Ch; Kastania A; Zoumpourlis V
Oncol Rep; 2012 Dec; 28(6):2200-4. PubMed ID: 23007659
[TBL] [Abstract][Full Text] [Related]
16. MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
Deng Y; Huang Z; Xu Y; Jin J; Zhuo W; Zhang C; Zhang X; Shen M; Yan X; Wang L; Wang X; Kang Y; Si J; Zhou T
Cancer Lett; 2014 Jan; 342(1):27-35. PubMed ID: 23981575
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and SerpinB3 in hepatocellular carcinoma.
Turato C; Simonato D; Quarta S; Gatta A; Pontisso P
Life Sci; 2014 Mar; 100(1):9-17. PubMed ID: 24496037
[TBL] [Abstract][Full Text] [Related]
18. miR-197: A novel biomarker for cancers.
Wang DD; Chen X; Yu DD; Yang SJ; Shen HY; Sha HH; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Oct; 591(2):313-9. PubMed ID: 27320730
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a: a potential therapeutic target in human cancer.
Li XJ; Ren ZJ; Tang JH
Cell Death Dis; 2014 Jul; 5(7):e1327. PubMed ID: 25032850
[TBL] [Abstract][Full Text] [Related]
20. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
Spizzo R; Rushworth D; Guerrero M; Calin GA
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
